Brown Regina 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Jan 22, 2025
Insider Transaction Report
Form 4
Brown Regina
Director
Transactions
- Award
Options to Purchase Common Stock
2025-01-20+4,924→ 4,924 totalExercise: $2.33From: 2025-01-20Exp: 2030-01-20→ Common (4,924 underlying)
Holdings
- 10,000
Options to Purchase Common Stock
Exercise: $7.45From: 2022-06-30Exp: 2027-06-30→ Common (10,000 underlying) - 6,269
Options to Purchase Common Stock
Exercise: $1.30From: 2024-09-30Exp: 2029-09-30→ Common (6,269 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $5.88From: 2023-06-30Exp: 2028-06-30→ Common (10,000 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $30.30From: 2021-06-30Exp: 2026-06-30→ Common (10,000 underlying) - 4,904
Options to Purchase Common Stock
Exercise: $2.37From: 2024-06-30Exp: 2029-06-30→ Common (4,904 underlying) - 25,000
Options to Purchase Common Stock
Exercise: $28.00From: 2021-05-11Exp: 2026-05-11→ Common (25,000 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $2.37From: 2024-06-30Exp: 2029-06-30→ Common (10,000 underlying)
Footnotes (1)
- [F1]Effective January 20, 2025, the reporting person was granted stock options to purchase an aggregate of 4,924 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan.